Viewing Study NCT01833169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-05-26 @ 6:05 PM
Study NCT ID: NCT01833169
Status: COMPLETED
Last Update Posted: 2018-10-19
First Post: 2013-04-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: BKM120 for Patients With PI3K-activated Tumors
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None PI3K Pathway Activated Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumor View
None malignancy View
None hematologic malignancy View
None PI3K pathway activation View
None P13K activated tumors View
None BKM120 View
None signature View
None AML View
None acute myelogenous leukemia View
None cervical View
None ovarian View
None hepatobiliary View
None buparlisib View